Paul Tudor Jones Iovance Biotherapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 218,927 shares of IOVA stock, worth $1.99 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

218,927

Previous 299,885 27.0%

Holding current value

$1.99 Million

Previous $2.41 Million 14.55%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.28 - $11.9 $589,374 - $963,400	-80,958 Reduced 27.0%	218,927 $2.06 Million
Q2 2024 Aug 14, 2024	BUY	$7.78 - $14.19 $429,992 - $784,267	55,269 Added 22.59%	299,885 $2.41 Million
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $1.61 Million - $3.69 Million	211,468 Added 637.95%	244,616 $3.63 Million
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $109,388 - $294,685	33,148 New	33,148 $269,000
Q2 2023 Aug 14, 2023	BUY	$5.36 - $9.06 $309,540 - $523,215	57,750 Added 100.39%	115,277 $811,000
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $205,174 - $304,978	-37,102 Reduced 39.21%	57,527 $351,000
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $89,071 - $158,490	15,849 Added 20.12%	94,629 $605,000
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $111,634 - $153,570	-11,714 Reduced 12.94%	78,780 $755,000
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $383,591 - $1.1 Million	60,124 Added 197.97%	90,494 $999,000
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $707,665 - $1.09 Million	-57,162 Reduced 65.3%	30,370 $506,000
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $654,552 - $1.09 Million	39,550 Added 82.43%	87,532 $1.67 Million
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $976,433 - $1.28 Million	47,982 New	47,982 $1.18 Million
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $2.45 Million - $4.96 Million	-150,091 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $4.3 Million - $7.89 Million	150,091 New	150,091 $4.75 Million
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $886,279 - $1.16 Million	-31,938 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $869,032 - $1.31 Million	31,938 New	31,938 $877,000
Q4 2017 Feb 14, 2018	SELL	$6.65 - $9.25 $126,350 - $175,750	-19,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.45 - $8.55 $84,550 - $162,450	19,000	19,000 $147,000

Others Institutions Holding IOVA

# of Institutions

314

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.43B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account